1-5 of 5 results for subject:"Medical treatments"
Librarians' tools
- Search time
- 0.18 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:"Medical treatments"
- We searched for
- subject_t:"Medical treatments" OR subject_ses:91973
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, what assessment he has made of the ability of NHS procurement to realise the benefits of medical technology that are accrued outside of NHS settings in social care or through savings in welfare and return to work spending.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the ability of NHS procurement to realise the benefits of medical technology that are accrued outside of NHS settings in social care or through savings in welfare and return to work spending.
The Category Tower Service Providers (part of the new NHS Supply Chain) contract has a number of savings methodologies included that will be verified and reported for customers. There is no specific reference in the NHS Supply Chain model to potential savings outside of the National Health Service, but as part of their Category Strategies providers can develop potential savings for identified life-cycle and patient pathways.
The NHS has multiple channels to market for innovators and every effort is made to ensure that innovations required by the NHS, are introduced with minimal delay. This is facilitated by the Accelerated Access Programme which was set up by the Office for Life Sciences.
For its part, NHS Supply Chain works with a plethora of NHS organisations involved with innovation to ensure that priority innovations are advanced, with appropriate commercial arrangements, to ensure product availability with minimal delay and at best value.
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the availability of ECMO beds this winter.
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the availability of ECMO beds this winter.
NHS England has actively monitored Extracorporeal Membrane Oxygenation (ECMO) bed capacity over winter. During the period 1 November 2017 to 31 March 2018, NHS England monitors capacity on a weekly basis (increasing this frequency if required). During periods of high demand, capacity can be increased in line with an agreed standard operating procedure.
There is no information to suggest that a patient who has been accepted for ECMO treatment has been unable to access it, either in the last 12 months or over the last five years. Any individual patient concerns about access to ECMO treatment would be most appropriately raised with the service provider or NHS England as the commissioner of ECMO services.
To ask the Secretary of State for Health and Social Care, whether any patients have been unable to access an ECMO bed after its use had been clinically recommended in each of the (a) last 12 months and (b) last five years.
To ask the Secretary of State for Health and Social Care, whether any patients have been unable to access an ECMO bed after its use had been clinically recommended in each of the (a) last 12 months and (b) last five years.
NHS England has actively monitored Extracorporeal Membrane Oxygenation (ECMO) bed capacity over winter. During the period 1 November 2017 to 31 March 2018, NHS England monitors capacity on a weekly basis (increasing this frequency if required). During periods of high demand, capacity can be increased in line with an agreed standard operating procedure.
There is no information to suggest that a patient who has been accepted for ECMO treatment has been unable to access it, either in the last 12 months or over the last five years. Any individual patient concerns about access to ECMO treatment would be most appropriately raised with the service provider or NHS England as the commissioner of ECMO services.
To ask the Secretary of State for Health and Social Care, if he will set out (a) how many and (b) which hospitals in England have provided extracorporeal membrane oxygenation treatment, in each year since 2010.
To ask the Secretary of State for Health and Social Care, if he will set out (a) how many and (b) which hospitals in England have provided extracorporeal membrane oxygenation treatment, in each year since 2010.
NHS England has contracting arrangements with five NHS trusts which have provided adult extracorporeal membrane oxygenation (ECMO) treatment in England in each year since 2013. These are:
- Guy’s and St Thomas’ NHS Foundation Trust;
- Papworth Hospital NHS Foundation Trust;
- Royal Brompton and Harefield NHS Foundation Trust;
- University Hospital of South Manchester NHS Foundation Trust; and
- University Hospitals of Leicester NHS Trust.
NHS England also has contracting arrangements with five NHS trusts which have provided paediatric ECMO treatment in England in each year since 2013. These are outlined below:
- University Hospitals of Leicester NHS Trust;
- Newcastle upon Tyne NHS Foundation Trust;
- Great Ormond Street Hospital Foundation Trust;
- Birmingham Women's and Children's NHS Foundation Trust; and
- Alder Hey Children’s NHS Foundation Trust.
Data prior to 2013 is not held centrally.
Published standard operating procedure on the NHS England website sets out the actions that NHS England and NHS trusts take to manage surges in demand for ECMO services. This is available via the following link:
To ask the Secretary of State for Health and Social Care, what contingency plans are in place if all nationally designated extra corporeal membrane oxygenation beds are in use.
To ask the Secretary of State for Health and Social Care, what contingency plans are in place if all nationally designated extra corporeal membrane oxygenation beds are in use.
NHS England has contracting arrangements with five NHS trusts which have provided adult extracorporeal membrane oxygenation (ECMO) treatment in England in each year since 2013. These are:
- Guy’s and St Thomas’ NHS Foundation Trust;
- Papworth Hospital NHS Foundation Trust;
- Royal Brompton and Harefield NHS Foundation Trust;
- University Hospital of South Manchester NHS Foundation Trust; and
- University Hospitals of Leicester NHS Trust.
NHS England also has contracting arrangements with five NHS trusts which have provided paediatric ECMO treatment in England in each year since 2013. These are outlined below:
- University Hospitals of Leicester NHS Trust;
- Newcastle upon Tyne NHS Foundation Trust;
- Great Ormond Street Hospital Foundation Trust;
- Birmingham Women's and Children's NHS Foundation Trust; and
- Alder Hey Children’s NHS Foundation Trust.
Data prior to 2013 is not held centrally.
Published standard operating procedure on the NHS England website sets out the actions that NHS England and NHS trusts take to manage surges in demand for ECMO services. This is available via the following link: